Home
Forums
New posts
Search forums
What's new
New posts
Latest activity
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Fred&#039;s Myth" data-source="post: 5071767" data-attributes="member: 55587"><p>They’re still testing applications against different diseases.</p><p></p><p><em>The synthesis and development of ivermectin by Merck in the 1970s and 1980s provided a breakthrough treatment against infectious diseases transmitted by parasites. This discovery resulted from an international collaboration that screened hundreds of natural products to identify a promising lead compound. Merck scientists synthesized thousands of analogs of this lead and tested them. The result, ivermectin, offered a highly effective treatment for several parasitic diseases affecting a variety of animals. Following its approval for human use in 1987, Merck established a worldwide program to donate ivermectin as Mectizan® to treat onchocerciasis (river blindness), greatly reducing the prevalence of this debilitating disease. In 2015, Merck scientist William Campbell shared the Nobel Prize in Physiology or Medicine for his role in developing ivermectin.</em></p></blockquote><p></p>
[QUOTE="Fred's Myth, post: 5071767, member: 55587"] They’re still testing applications against different diseases. [I]The synthesis and development of ivermectin by Merck in the 1970s and 1980s provided a breakthrough treatment against infectious diseases transmitted by parasites. This discovery resulted from an international collaboration that screened hundreds of natural products to identify a promising lead compound. Merck scientists synthesized thousands of analogs of this lead and tested them. The result, ivermectin, offered a highly effective treatment for several parasitic diseases affecting a variety of animals. Following its approval for human use in 1987, Merck established a worldwide program to donate ivermectin as Mectizan® to treat onchocerciasis (river blindness), greatly reducing the prevalence of this debilitating disease. In 2015, Merck scientist William Campbell shared the Nobel Prize in Physiology or Medicine for his role in developing ivermectin.[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
Top